Treatment of Female Stress Urinary Incontinence with Bulkamid

Introduction to Bulkamid

• Bulkamid is a urethral bulking agent used primarily for treating female stress urinary incontinence (SUI) as a minimally invasive alternative to more complex surgical procedures, according to the American Urological Association 1

Efficacy and Advantages

• Bulkamid demonstrates longer persistence of effect (up to 96 months) compared to other agents, with no erosions noted in patients, unlike with other bulking agents 1
• Bulkamid has a lower satisfaction rate compared to tension-free vaginal tape (TVT) procedures, though the majority of women treated with PAHG are still considered cured or improved at 3-year follow-up, as reported by the American Urological Association 1

Patient Selection and Limitations

• Bulkamid may not be recommended as first-line treatment for patients with fixed immobile urethra, as autologous pubovaginal sling is preferred, according to the American Urological Association 1

Safety Profile

• No serious product-specific adverse events have been reported, with most common complications including transient urinary retention, urinary tract infections, and dysuria, as noted by the medical literature 1